Global Biosimulation Software 麻豆原创 Research Report 2024

Publication ID:

PB511246736

Publication Date:

November 13, 2024

Pages:

105

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

IT Services [2]

Computing & Electronics [3]

Description:

The global Biosimulation Software market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
Biosimulation software is a type of computational tool used to model and simulate biological processes and systems. These programs enable researchers and scientists to predict the behavior of biological entities, such as cells, tissues, and entire organisms, under various conditions. By using mathematical models and algorithms, biosimulation software can help in understanding complex biological interactions, drug interactions, metabolic pathways, and disease progression.
North American market for Biosimulation Software is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Biosimulation Software is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Biosimulation Software in Pharmaceuticals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Biosimulation Software include Certara, Simulations, Dassault Syst猫mes, 厂肠丑谤枚诲颈苍驳别谤, Advanced Chemistry, Chemical Computing, Rosa & Co., Genedata, Physiomics, In Silico Biosciences, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Biosimulation Software, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biosimulation Software.
The Biosimulation Software market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Biosimulation Software market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biosimulation Software companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Certara
Simulations
Dassault Syst猫mes
厂肠丑谤枚诲颈苍驳别谤
Advanced Chemistry
Chemical Computing
Rosa & Co.
Genedata
Physiomics
In Silico Biosciences
Allucent
OpenEye (Cadence)
Cellworks Group
VeriSIM Life
Netabolics SRL
Charnwood Discovery
The MathWorks
ANSYS
Instem Group of Companies
Insilico Medicine
SCM
BioSymetrics
Atomwise
insitro
Clinithink
Segment by Type
Independent Modules
Integrated Software Platform
Segment by Application
Pharmaceuticals
Medical Research
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biosimulation Software company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Biosimulation Software 麻豆原创 Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Independent Modules
1.2.3 Integrated Software Platform
1.3 麻豆原创 by Application
1.3.1 Global Biosimulation Software 麻豆原创 Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceuticals
1.3.3 Medical Research
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biosimulation Software 麻豆原创 Perspective (2019-2030)
2.2 Global Biosimulation Software Growth Trends by Region
2.2.1 Global Biosimulation Software 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 Biosimulation Software Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 Biosimulation Software Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 Biosimulation Software 麻豆原创 Dynamics
2.3.1 Biosimulation Software Industry Trends
2.3.2 Biosimulation Software 麻豆原创 Drivers
2.3.3 Biosimulation Software 麻豆原创 Challenges
2.3.4 Biosimulation Software 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biosimulation Software Players by Revenue
3.1.1 Global Top Biosimulation Software Players by Revenue (2019-2024)
3.1.2 Global Biosimulation Software Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Biosimulation Software 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Biosimulation Software Revenue
3.4 Global Biosimulation Software 麻豆原创 Concentration Ratio
3.4.1 Global Biosimulation Software 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biosimulation Software Revenue in 2023
3.5 Global Key Players of Biosimulation Software Head office and Area Served
3.6 Global Key Players of Biosimulation Software, Product and Application
3.7 Global Key Players of Biosimulation Software, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Biosimulation Software Breakdown Data by Type
4.1 Global Biosimulation Software Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global Biosimulation Software Forecasted 麻豆原创 Size by Type (2025-2030)
5 Biosimulation Software Breakdown Data by Application
5.1 Global Biosimulation Software Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global Biosimulation Software Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America Biosimulation Software 麻豆原创 Size (2019-2030)
6.2 North America Biosimulation Software 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Biosimulation Software 麻豆原创 Size by Country (2019-2024)
6.4 North America Biosimulation Software 麻豆原创 Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biosimulation Software 麻豆原创 Size (2019-2030)
7.2 Europe Biosimulation Software 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Biosimulation Software 麻豆原创 Size by Country (2019-2024)
7.4 Europe Biosimulation Software 麻豆原创 Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biosimulation Software 麻豆原创 Size (2019-2030)
8.2 Asia-Pacific Biosimulation Software 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Biosimulation Software 麻豆原创 Size by Region (2019-2024)
8.4 Asia-Pacific Biosimulation Software 麻豆原创 Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biosimulation Software 麻豆原创 Size (2019-2030)
9.2 Latin America Biosimulation Software 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Biosimulation Software 麻豆原创 Size by Country (2019-2024)
9.4 Latin America Biosimulation Software 麻豆原创 Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biosimulation Software 麻豆原创 Size (2019-2030)
10.2 Middle East & Africa Biosimulation Software 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Biosimulation Software 麻豆原创 Size by Country (2019-2024)
10.4 Middle East & Africa Biosimulation Software 麻豆原创 Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Certara
11.1.1 Certara Company Details
11.1.2 Certara Business Overview
11.1.3 Certara Biosimulation Software Introduction
11.1.4 Certara Revenue in Biosimulation Software Business (2019-2024)
11.1.5 Certara Recent Development
11.2 Simulations
11.2.1 Simulations Company Details
11.2.2 Simulations Business Overview
11.2.3 Simulations Biosimulation Software Introduction
11.2.4 Simulations Revenue in Biosimulation Software Business (2019-2024)
11.2.5 Simulations Recent Development
11.3 Dassault Syst猫mes
11.3.1 Dassault Syst猫mes Company Details
11.3.2 Dassault Syst猫mes Business Overview
11.3.3 Dassault Syst猫mes Biosimulation Software Introduction
11.3.4 Dassault Syst猫mes Revenue in Biosimulation Software Business (2019-2024)
11.3.5 Dassault Syst猫mes Recent Development
11.4 厂肠丑谤枚诲颈苍驳别谤
11.4.1 厂肠丑谤枚诲颈苍驳别谤 Company Details
11.4.2 厂肠丑谤枚诲颈苍驳别谤 Business Overview
11.4.3 厂肠丑谤枚诲颈苍驳别谤 Biosimulation Software Introduction
11.4.4 厂肠丑谤枚诲颈苍驳别谤 Revenue in Biosimulation Software Business (2019-2024)
11.4.5 厂肠丑谤枚诲颈苍驳别谤 Recent Development
11.5 Advanced Chemistry
11.5.1 Advanced Chemistry Company Details
11.5.2 Advanced Chemistry Business Overview
11.5.3 Advanced Chemistry Biosimulation Software Introduction
11.5.4 Advanced Chemistry Revenue in Biosimulation Software Business (2019-2024)
11.5.5 Advanced Chemistry Recent Development
11.6 Chemical Computing
11.6.1 Chemical Computing Company Details
11.6.2 Chemical Computing Business Overview
11.6.3 Chemical Computing Biosimulation Software Introduction
11.6.4 Chemical Computing Revenue in Biosimulation Software Business (2019-2024)
11.6.5 Chemical Computing Recent Development
11.7 Rosa & Co.
11.7.1 Rosa & Co. Company Details
11.7.2 Rosa & Co. Business Overview
11.7.3 Rosa & Co. Biosimulation Software Introduction
11.7.4 Rosa & Co. Revenue in Biosimulation Software Business (2019-2024)
11.7.5 Rosa & Co. Recent Development
11.8 Genedata
11.8.1 Genedata Company Details
11.8.2 Genedata Business Overview
11.8.3 Genedata Biosimulation Software Introduction
11.8.4 Genedata Revenue in Biosimulation Software Business (2019-2024)
11.8.5 Genedata Recent Development
11.9 Physiomics
11.9.1 Physiomics Company Details
11.9.2 Physiomics Business Overview
11.9.3 Physiomics Biosimulation Software Introduction
11.9.4 Physiomics Revenue in Biosimulation Software Business (2019-2024)
11.9.5 Physiomics Recent Development
11.10 In Silico Biosciences
11.10.1 In Silico Biosciences Company Details
11.10.2 In Silico Biosciences Business Overview
11.10.3 In Silico Biosciences Biosimulation Software Introduction
11.10.4 In Silico Biosciences Revenue in Biosimulation Software Business (2019-2024)
11.10.5 In Silico Biosciences Recent Development
11.11 Allucent
11.11.1 Allucent Company Details
11.11.2 Allucent Business Overview
11.11.3 Allucent Biosimulation Software Introduction
11.11.4 Allucent Revenue in Biosimulation Software Business (2019-2024)
11.11.5 Allucent Recent Development
11.12 OpenEye (Cadence)
11.12.1 OpenEye (Cadence) Company Details
11.12.2 OpenEye (Cadence) Business Overview
11.12.3 OpenEye (Cadence) Biosimulation Software Introduction
11.12.4 OpenEye (Cadence) Revenue in Biosimulation Software Business (2019-2024)
11.12.5 OpenEye (Cadence) Recent Development
11.13 Cellworks Group
11.13.1 Cellworks Group Company Details
11.13.2 Cellworks Group Business Overview
11.13.3 Cellworks Group Biosimulation Software Introduction
11.13.4 Cellworks Group Revenue in Biosimulation Software Business (2019-2024)
11.13.5 Cellworks Group Recent Development
11.14 VeriSIM Life
11.14.1 VeriSIM Life Company Details
11.14.2 VeriSIM Life Business Overview
11.14.3 VeriSIM Life Biosimulation Software Introduction
11.14.4 VeriSIM Life Revenue in Biosimulation Software Business (2019-2024)
11.14.5 VeriSIM Life Recent Development
11.15 Netabolics SRL
11.15.1 Netabolics SRL Company Details
11.15.2 Netabolics SRL Business Overview
11.15.3 Netabolics SRL Biosimulation Software Introduction
11.15.4 Netabolics SRL Revenue in Biosimulation Software Business (2019-2024)
11.15.5 Netabolics SRL Recent Development
11.16 Charnwood Discovery
11.16.1 Charnwood Discovery Company Details
11.16.2 Charnwood Discovery Business Overview
11.16.3 Charnwood Discovery Biosimulation Software Introduction
11.16.4 Charnwood Discovery Revenue in Biosimulation Software Business (2019-2024)
11.16.5 Charnwood Discovery Recent Development
11.17 The MathWorks
11.17.1 The MathWorks Company Details
11.17.2 The MathWorks Business Overview
11.17.3 The MathWorks Biosimulation Software Introduction
11.17.4 The MathWorks Revenue in Biosimulation Software Business (2019-2024)
11.17.5 The MathWorks Recent Development
11.18 ANSYS
11.18.1 ANSYS Company Details
11.18.2 ANSYS Business Overview
11.18.3 ANSYS Biosimulation Software Introduction
11.18.4 ANSYS Revenue in Biosimulation Software Business (2019-2024)
11.18.5 ANSYS Recent Development
11.19 Instem Group of Companies
11.19.1 Instem Group of Companies Company Details
11.19.2 Instem Group of Companies Business Overview
11.19.3 Instem Group of Companies Biosimulation Software Introduction
11.19.4 Instem Group of Companies Revenue in Biosimulation Software Business (2019-2024)
11.19.5 Instem Group of Companies Recent Development
11.20 Insilico Medicine
11.20.1 Insilico Medicine Company Details
11.20.2 Insilico Medicine Business Overview
11.20.3 Insilico Medicine Biosimulation Software Introduction
11.20.4 Insilico Medicine Revenue in Biosimulation Software Business (2019-2024)
11.20.5 Insilico Medicine Recent Development
11.21 SCM
11.21.1 SCM Company Details
11.21.2 SCM Business Overview
11.21.3 SCM Biosimulation Software Introduction
11.21.4 SCM Revenue in Biosimulation Software Business (2019-2024)
11.21.5 SCM Recent Development
11.22 BioSymetrics
11.22.1 BioSymetrics Company Details
11.22.2 BioSymetrics Business Overview
11.22.3 BioSymetrics Biosimulation Software Introduction
11.22.4 BioSymetrics Revenue in Biosimulation Software Business (2019-2024)
11.22.5 BioSymetrics Recent Development
11.23 Atomwise
11.23.1 Atomwise Company Details
11.23.2 Atomwise Business Overview
11.23.3 Atomwise Biosimulation Software Introduction
11.23.4 Atomwise Revenue in Biosimulation Software Business (2019-2024)
11.23.5 Atomwise Recent Development
11.24 insitro
11.24.1 insitro Company Details
11.24.2 insitro Business Overview
11.24.3 insitro Biosimulation Software Introduction
11.24.4 insitro Revenue in Biosimulation Software Business (2019-2024)
11.24.5 insitro Recent Development
11.25 Clinithink
11.25.1 Clinithink Company Details
11.25.2 Clinithink Business Overview
11.25.3 Clinithink Biosimulation Software Introduction
11.25.4 Clinithink Revenue in Biosimulation Software Business (2019-2024)
11.25.5 Clinithink Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 麻豆原创 Size Estimation
13.1.1.3 麻豆原创 Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

Companies Mentioned:

Certara
Simulations
Dassault Syst猫mes
厂肠丑谤枚诲颈苍驳别谤
Advanced Chemistry
Chemical Computing
Rosa & Co.
Genedata
Physiomics
In Silico Biosciences
Allucent
OpenEye (Cadence)
Cellworks Group
VeriSIM Life
Netabolics SRL
Charnwood Discovery
The MathWorks
ANSYS
Instem Group of Companies
Insilico Medicine
SCM
BioSymetrics
Atomwise
insitro
Clinithink

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.